BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Huang W, Zhang Q, Li W, Chen Y, Shu C, Li Q, Zhou J, Ye C, Bai H, Sun W, Yang X, Ma Y. Anti-outer Membrane Vesicle Antibodies Increase Antibiotic Sensitivity of Pan-Drug-Resistant Acinetobacter baumannii. Front Microbiol 2019;10:1379. [PMID: 31275290 DOI: 10.3389/fmicb.2019.01379] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
Number Citing Articles
1 Furuyama N, Sircili MP. Outer Membrane Vesicles (OMVs) Produced by Gram-Negative Bacteria: Structure, Functions, Biogenesis, and Vaccine Application. Biomed Res Int 2021;2021:1490732. [PMID: 33834062 DOI: 10.1155/2021/1490732] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Nie D, Hu Y, Chen Z, Li M, Hou Z, Luo X, Mao X, Xue X. Outer membrane protein A (OmpA) as a potential therapeutic target for Acinetobacter baumannii infection. J Biomed Sci 2020;27:26. [PMID: 31954394 DOI: 10.1186/s12929-020-0617-7] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 15.0] [Reference Citation Analysis]
3 Chiang MH, Yang YS, Sun JR, Wang YC, Kuo SC, Lee YT, Chuang YP, Chen TL. Confronting Tigecycline-Resistant Acinetobacter baumannii via Immunization Against Conserved Resistance Determinants. Front Microbiol 2020;11:536. [PMID: 32296411 DOI: 10.3389/fmicb.2020.00536] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
4 Khodadadi E, Zeinalzadeh E, Taghizadeh S, Mehramouz B, Kamounah FS, Khodadadi E, Ganbarov K, Yousefi B, Bastami M, Kafil HS. Proteomic Applications in Antimicrobial Resistance and Clinical Microbiology Studies. Infect Drug Resist 2020;13:1785-806. [PMID: 32606829 DOI: 10.2147/IDR.S238446] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
5 Tarashi S, Zamani MS, Omrani MD, Fateh A, Moshiri A, Saedisomeolia A, Siadat SD, Kubow S, Torrecilhas AC. Commensal and Pathogenic Bacterial-Derived Extracellular Vesicles in Host-Bacterial and Interbacterial Dialogues: Two Sides of the Same Coin. Journal of Immunology Research 2022;2022:1-15. [DOI: 10.1155/2022/8092170] [Reference Citation Analysis]
6 Gellings PS, Wilkins AA, Morici LA. Recent Advances in the Pursuit of an Effective Acinetobacter baumannii Vaccine. Pathogens 2020;9:E1066. [PMID: 33352688 DOI: 10.3390/pathogens9121066] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
7 Yeganeh O, Shabani M, Pakzad P, Mosaffa N, Hashemi A. Production and characterization of novel monoclonal antibodies against outer membrane protein A (OmpA) of Acinetobacter baumannii. J Immunol Methods 2021;499:113169. [PMID: 34666009 DOI: 10.1016/j.jim.2021.113169] [Reference Citation Analysis]
8 Gan Y, Li C, Peng X, Wu S, Li Y, Tan JPK, Yang YY, Yuan P, Ding X. Fight bacteria with bacteria: Bacterial membrane vesicles as vaccines and delivery nanocarriers against bacterial infections. Nanomedicine 2021;35:102398. [PMID: 33901646 DOI: 10.1016/j.nano.2021.102398] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Kesavan D, Vasudevan A, Wu L, Chen J, Su Z, Wang S, Xu H. Integrative analysis of outer membrane vesicles proteomics and whole-cell transcriptome analysis of eravacycline induced Acinetobacter baumannii strains. BMC Microbiol 2020;20:31. [PMID: 32046644 DOI: 10.1186/s12866-020-1722-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
10 Behrens F, Funk-Hilsdorf TC, Kuebler WM, Simmons S. Bacterial Membrane Vesicles in Pneumonia: From Mediators of Virulence to Innovative Vaccine Candidates. Int J Mol Sci 2021;22:3858. [PMID: 33917862 DOI: 10.3390/ijms22083858] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Long Q, Zheng P, Zheng X, Li W, Hua L, Yang Z, Huang W, Ma Y. Engineered bacterial membrane vesicles are promising carriers for vaccine design and tumor immunotherapy. Advanced Drug Delivery Reviews 2022. [DOI: 10.1016/j.addr.2022.114321] [Reference Citation Analysis]
12 Gilmore WJ, Bitto NJ, Kaparakis-Liaskos M. Pathogenesis Mediated by Bacterial Membrane Vesicles. Subcell Biochem 2021;97:101-50. [PMID: 33779916 DOI: 10.1007/978-3-030-67171-6_6] [Reference Citation Analysis]
13 de Freitas SB, Wozeak DR, Neto AS, Cardoso TL, Hartwig DD. A hypothetical adhesin protein induces anti-biofilm antibodies against multi-drug resistant Acinetobacter baumannii. Microb Pathog 2021;159:105112. [PMID: 34314810 DOI: 10.1016/j.micpath.2021.105112] [Reference Citation Analysis]
14 Tiku V, Tan MW. Host immunity and cellular responses to bacterial outer membrane vesicles. Trends Immunol 2021;42:1024-36. [PMID: 34635395 DOI: 10.1016/j.it.2021.09.006] [Reference Citation Analysis]
15 Gilmore WJ, Johnston EL, Zavan L, Bitto NJ, Kaparakis-Liaskos M. Immunomodulatory roles and novel applications of bacterial membrane vesicles. Mol Immunol 2021;134:72-85. [PMID: 33725501 DOI: 10.1016/j.molimm.2021.02.027] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
16 Ma C, Chen W. Where are we and how far is there to go in the development of an Acinetobacter vaccine? Expert Rev Vaccines 2021;20:281-95. [PMID: 33554671 DOI: 10.1080/14760584.2021.1887735] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]